Summary
64 / 100 · Bulios Score
What speaks for it
- Revenue grew by 18% a year over the last 3 years.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- The share price is above the Bulios Fair Price.
- Its last loss-making year was 2 years ago.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.3 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
Revenue grew by 43% a year over 5 years. Over the last 3 years it grew by 18% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 82 EUR
- Sales and administration 18 EUR
- Taxes and other -7.2 EUR
- Net profit 7.1 EUR
Net profit, industry median (Advertising Agencies) 2.8 EUR
Out of every 100 EUR of revenue, 7.1 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.88%
- Paid out of profit
- 6.5%
You receive 0.18 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail